Literature DB >> 28913761

Radioactive Seed Localization Versus Wire-Guided Localization for Nonpalpable Breast Cancer: A Cost and Operating Room Efficiency Analysis.

Yimeng Zhang1, Jean Seely2, Erin Cordeiro1, Joshua Hefler3, Kednapa Thavorn4,5,6, Mukta Mahajan2, Sue Domina2, Jon Aro7, Andrea Marie Ibrahim4, Angel Arnaout1, Denis Gravel8, Carolyn Nessim9.   

Abstract

BACKGROUND: This study aimed to compare the cost and resource use between our first-year experience using breast-conserving surgery (BCS) with radioactive seed localization (RSL) and the previous-year standard practice of BCS with wire-guided localization (WGL) for patients with nonpalpable breast cancer at a large Canadian tertiary center.
METHODS: For this retrospective cohort study, data for BCS cases with RSL was collected from 1 April 2015 to 31 March 2016 and for BCS cases with WGL from 1 April 2014 to 31 March 2015.
RESULTS: The study compared 153 WGL patients with 194 RSL patients. The two groups had no significant demographic differences. The average cost per patient for RSL, including opportunity costs, was $250.90 versus $1130.41 for WGL. Dedicated allocated radiology appointments to RSL increased (9 per day), and fewer radiologists were required for these procedures per day. Patients were transported to the operating room more quickly for RSL procedures (120 vs. 254 min; p < 0.001). Fewer vasovagal reactions occurred after insertion of RSL versus WGL (p = 0.05). No significant differences were observed in terms of surgical time, specimen volume, positive margins, or margin reexcision rates. No significant differences in postoperative complication rates were observed.
CONCLUSIONS: In this study, RSL had lower costs than WGL, allowed for more efficient use of radiology scheduling and resources, and had shorter wait times for patients on their day of surgery. In addition, RSL led to fewer vasovagal reactions at insertion. Therefore, RSL should be used instead of WGL given the reduced cost, decreased need of human resources, improved efficiency, and potential benefits to the patient experience.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28913761     DOI: 10.1245/s10434-017-6084-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Histological changes secondary to wire coil placement in breast tissue and lymph nodes.

Authors:  Ignacio Pinilla-Pagnon; Belén Pérez-Mies; María Eugenia Reguero; Marco-Tulio Martinez; Miguel Chiva; Silvia Pérez-Rodrigo; Odile Ajuria Illarramendi; Maria Eugenia Rioja Martin; Maria Vicenta Collado; Maria Concepción Sanchez; Juan Manuel Rosa-Rosa; José Palacios
Journal:  Virchows Arch       Date:  2018-07-08       Impact factor: 4.064

2.  ASO Author Reflections: Which Preoperative Breast Localization Method is More Economical: Radioactive Seed or Wire-Guided Localization?

Authors:  Wyanne Law; Nicole Look Hong; Ananth Ravi; Frances C Wright; Belinda Curpen
Journal:  Ann Surg Oncol       Date:  2020-10-19       Impact factor: 5.344

3.  Budget Impact Analysis of Preoperative Radioactive Seed Localization.

Authors:  Wyanne Law; Nicole Look Hong; Ananth Ravi; Lisa Day; Yasmin Somani; Frances C Wright; Sharon Nofech-Mozes; William T Tran; Belinda Curpen
Journal:  Ann Surg Oncol       Date:  2020-09-01       Impact factor: 5.344

4.  Wireless Breast Localization Using Radio-frequency Identification Tags: The First Reported European Experience in Breast Cancer.

Authors:  Umar Wazir; Salim Tayeh; Nicholas Perry; Michael Michell; Anmol Malhotra; Kefah Mokbel
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

5.  Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery.

Authors:  Melanie Lindenberg; Anne van Beek; Valesca Retèl; Frederieke van Duijnhoven; Wim van Harten
Journal:  PLoS One       Date:  2020-05-13       Impact factor: 3.240

6.  Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study.

Authors:  James R Harvey; Yit Lim; John Murphy; Miles Howe; Julie Morris; Amit Goyal; Anthony J Maxwell
Journal:  Breast Cancer Res Treat       Date:  2018-02-16       Impact factor: 4.872

7.  Evaluation of the nonradioactive inducible magnetic seed system Magseed for preoperative localization of nonpalpable breast lesions - initial clinical experience.

Authors:  Karolina Pieszko; Mateusz Wichtowski; Marcin Cieciorowski; Robert Jamont; Dawid Murawa
Journal:  Contemp Oncol (Pozn)       Date:  2020-03-13

8.  Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions.

Authors:  Nicole Look Hong; Frances C Wright; Mark Semple; Alexandru M Nicolae; Ananth Ravi
Journal:  Breast Cancer Res Treat       Date:  2019-11-21       Impact factor: 4.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.